Insmed
INSM
#1127
Rank
NZ$36.42 B
Marketcap
NZ$168.04
Share price
-2.85%
Change (1 day)
-10.66%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -NZ$1.88 Billion

According to Insmed's latest financial reports the company's current earnings are NZ$0.81 Billion. In 2025 the company made an earning of -NZ$2.04 Billion a decrease over its 2024 earnings that were of -NZ$1.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.88 Billion-7.75%
2025 -NZ$2.04 Billion43.91%
2024 -NZ$1.42 Billion23.71%
2023 -NZ$1.15 Billion45.77%
2022 -NZ$0.79 Billion15.83%
2021 -NZ$0.68 Billion50.19%
2020 -NZ$0.46 Billion16.4%
2019 -NZ$0.39 Billion-23.9%
2018 -NZ$0.51 Billion59.35%
2017 -NZ$0.32 Billion8.52%
2016 -NZ$0.3 Billion47.25%
2015 -NZ$0.2 Billion34.53%
2014 -NZ$0.15 Billion58.83%
2013 -NZ$93.54 Million35.14%
2012 -NZ$69.22 Million-31.92%
2011 -NZ$0.11 Billion854.92%
2010 -NZ$10.65 Million-105.22%
2009 NZ$0.20 B-905.06%
2008 -NZ$25.33 Million-27.31%
2007 -NZ$34.84 Million-62.41%
2006 -NZ$92.67 Million98.19%
2005 -NZ$46.76 Million0.03%
2004 -NZ$46.75 Million159.07%
2003 -NZ$18.05 Million-69.31%
2002 -NZ$58.79 Million
2000 -NZ$53.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$26.90 B-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$18.28 B-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.62 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$41.69 M-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$39.61 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-NZ$40.08 Million-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA